Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33678 NOVABAY PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 68-0454536 ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q4 2021 Earnings Conference Call March 29, 2022 4:30 PM ET Company Participants Jody Cain - Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Conference Call Participants Destiny Hance - Ladenburg Thalmann Ed Woo - Ascendiant Capital Operator Good afternoon and welcome to the NovaBay Pharmaceuticals Fourth Quarter 2021 Financial Results Conference Call. All participants will be in listen-only mode. [Oper ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33678 NOVABAY PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdic ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Jody Cain ??? Investor Relations, LHA Justin Hall ??? Chief Executive Officer and General Counsel Andy Jones ??? Chief Financial Officer Audrey Kunin ??? Chief Product Officer Conference Call Participants Jeffrey Cohen ??? Ladenburg Thalmann Edward Woo ??? Ascendiant Capital Operator Good day, and welcome to the NovaBay Pharmaceuticals Third Quarter 2021 Financial Results Conference Ca ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33678 NOVABAY PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 68-04 ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) DERMAdoctor Acquisition Conference Call September 29, 2021 4:30 PM ET Company Participants Jody Cain - SVP, LHA, IR Justin Hall - CEO Audrey Kunin - DERMAdoctor, Co-Founder and Chief Product Officer Jeffrey Kunin - DERMAdoctor President, CEO and Co-Founder Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Inc. Edward Woo - Ascendiant Capital Markets, LLC Operator Welcome to the NovaBay Pharmaceuticals and DERMAdoctor Acquisition Conference Call. A ...

NovaBay Pharmaceuticals DERMAdoctor Transaction Conference Call Speakers: Justin M. Hall NovaBay CEO Dr. Audrey Kunin DERMAdoctor co-founder & Chief Product Officer September 29, 2021 - DERMAdoctor® ltle Official! We're thrilled to announce that DERMAdoctor NYSE American: NBY | Novabay.com | Avenova.com | Cellerx.com | Dermadoctor.com | Forward-Looking Statements This presentation contains forward-looking statements, within the meaning of applicable U.S. securities laws, which statements can, in some cases, ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Jody Cain - IR-LHA Justin Hall - CEO and General Counsel Andy Jones - CFO Conference Call Participants Operator Good day, and welcome to the NovaBay Pharmaceuticals Second Quarter 2021 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead. Jody Cain This is Jo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33678 NOVABAY PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 68-0454536 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 2000 Powell Street, Suite 1150, Emery ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Jody Cain - Investor Relations-LHA Justin Hall - President and Chief Executive Officer Andy Jones - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Ed Woo - Ascendiant Capital Operator Hello and welcome to the NovaBay Pharmaceuticals First Quarter 2021 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instruct ...